|
Obesity & Prediabetes:Mechanisms linking fat to CV disease
|
|
|
Inflammation, Obesity, Diabetes and Cardiovascular Disease
|
|
|
Acute inflammation
|
|
|
Chronic inflammation
|
|
|
Excess Adipose Tissue Can Cause Increased Expression of Some Hormones and the Suppression of Others and Can Lead to Inflammation and Disease
|
|
|
Evidence for Inflammatory Activation in Obesity in Humans
|
|
|
Other factors contributing to chronic inflammation
|
|
|
Cytokines
|
|
|
Adipocytokines
|
|
|
Adiponectin
|
|
|
Adiponectin
|
|
|
CRP
|
|
|
Obesity and CRP Levels: NHANES 1988-1994
|
|
|
Differences Between Visceral (VAT) AndSubcutaneous (SAT) Adipose Tissue
|
|
|
Is the “Inflammation” of Obesity More than an Epiphenomena?
|
|
|
Fat distribution and inflammation in men and women in the KORA Study
|
|
|
Central adiposity and inflammatory markers in men in the ATTICA study
|
|
|
Genetic polymorphisms that increase cytokines promote diabetes
|
|
|
Obesity, Inflammation and Metabolic Syndrome
|
|
|
Liposuction and metabolic function
|
|
|
Effect of weight loss and steady state reduced fat mass on inflammatory markers
|
|
|
Obesity,inflammationandandcardiovasculardisease
|
|
|
Lifestyle
|
|
|
Conclusions
|
|
|
Classical view of adipose tissue
|
|
|
Metabolic Profiles of Two Subgroups of Obese Men Matched for Age and % Body Fat
|
|
|
Most fat is healthy
|
|
|
‘Ectopic’Fat
|
|
|
Inflammation and Atherosclerosis
|
|
|
Unifying model: from endothelial dysfunction to CV disease
|
|
|
RelationshipbetweenadiponectinandPAI-1inoverweightorobesewomen(2)
|
|
|
Adipose tissue: production of substrates, cytokines and hormones
|
|
|
Obesity, Inflammation and diabetes
|
|
|
Hypothetical interaction of obstructive sleep apnea syndrome and obesity in activatingpathways leading to metabolic disease
|
|
|
Shared inflammatory pathways associated with obesity and obstructive sleep apnea syndrome and increased cardiovascular disease risk
|
|
|
Summary of Adipose Tissue Dysfunction in Obesity
|
|
Share this page with your colleagues and friends: